Method for preparing cyclodextrin metal organic framework material under assistance of supercritical carbon dioxide and application of cyclodextrin metal organic framework material

By using supercritical carbon dioxide assisted technology in the preparation of CD-MOF, the problem of time-consuming and poor environmental protection of cyclodextrin metal organic framework materials in the prior art is solved, and high-efficiency, low-energy consumption nano-level material synthesis and good Drug carrying performance.

CN118978708AActive Publication Date: 2024-11-19INNER MONGOLIA UNIV OF TECH

Patent Information

Application Number
CN202411077872.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-07
Publication Date
2024-11-19
Estimated Expiration
2044-08-07

AI Technical Summary

Technical Problem

In the prior art, the preparation method of cyclodextrin metal organic framework (CD-MOF) has problems such as excessive reaction time, large amount of organic solvents, poor environmental protection and high time-consuming and energy-consuming, and has not used supercritical carbon dioxide (SC- CO2) technology.

Method used

The method of preparing cyclodextrin metal organic framework materials by supercritical carbon dioxide assisted, by filling supercritical CO2 into a mixed solution filled with methanol vapor, potassium ions and γ-cyclodextrin can be used to achieve high stability through coordination. Nano-scale CD-MOF materials reduce methanol usage, shorten process time, improve yield and preparation efficiency.

Benefits of technology

It realizes efficient synthesis of nano-scale CD-MOF materials with high stability under mild operating conditions, reduces methanol usage and process time, improves preparation efficiency, reduces energy consumption and environmental risks, and the material has good drug-carrying properties.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118978708A_ABST
    Figure CN118978708A_ABST
Patent Text Reader

Abstract

The invention relates to a method for preparing a cyclodextrin metal organic framework material under the assistance of supercritical carbon dioxide, which comprises the following steps: dissolving gamma-cyclodextrin and potassium salt in water, filtering into a container through a filter membrane, adding methanol, and enabling the volume ratio of methanol to water to be (3-7): (1-5) to obtain a reaction solution; transferring the reaction liquid into a high-pressure reaction kettle for preheating; introducing CO2 until the pressure reaches 8-14 MPa, and carrying out heating and stirring reaction; after the reaction is finished, after the high-pressure reaction kettle is naturally cooled to room temperature, releasing the pressure, transferring out reactants in the high-pressure reaction kettle, adding a PEG20000 methanol solution, mixing the PEG20000 methanol solution with the reactants, and standing in cold water for 2-4 hours; and centrifuging at 5000-10000 rpm, collecting the precipitate, washing, and drying to obtain the cyclodextrin metal organic framework material CD-MOF. According to the method, the methanol consumption can be reduced, the process time consumption is greatly shortened, the leakage risk caused by long-time methanol steam diffusion is reduced, and the yield and the preparation efficiency of the CD-MOF are improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of drug delivery carriers, and in particular to a method and application of preparing cyclodextrin metal organic framework materials with the assistance of supercritical carbon dioxide. Background Art

[0002] Metal-organic framework (MOF) is a new type of porous material self-assembled by organic ligands and metal ions through coordination, and has application value in many fields. However, its potential toxicity and non-degradability limit its application in the field of food and medicine. Cyclodextrin metal-organic framework (γ-clodextrin-metal-organic framework, CD-MOF), as a new type of cyclodextrin derivative, has the advantages of simple synthesis method and food-grade raw materials. It is a kind of green and edible metal-organic framework, which has been applied to drug delivery, gas storage, separation, catalysis and many other fields. At present, the main synthesis methods of CD-MOF include vapor diffusion method, solvothermal method, microwave-assisted method, ultrasound-assisted method, seed growth method and other methods. These methods generally have technical problems such as long reaction time, large amount of organic solvents, poor environmental protection and time-consuming and energy-consuming. For example, CN116712567A discloses a vapor diffusion method for preparing γ-CD-MOF, including: dissolving γ-cyclodextrin and a water-soluble potassium salt in water to obtain a mixed solution, filtering the mixed solution into a reaction container through a filter membrane, and then placing the reaction container in a methanol vapor atmosphere to allow the methanol vapor to diffuse into the solution for 3-8 hours, taking out the supernatant, adding hexadecyltrimethylammonium bromide and methanol to the supernatant, and incubating the obtained suspension at room temperature for another 3-8 hours, and then collecting the precipitate by centrifugation. After washing the collected precipitate with methanol, it is vacuum dried at 40-60°C for 8-12 hours to obtain crystalline γ-CD-MOF. This scheme is time-consuming, complicated to operate, requires a large amount of methanol, and the methanol vapor diffusion takes 3-8 hours. Long-term diffusion is prone to methanol leakage. At the same time, supercritical CO 2 Fluid (SC-CO 2 ) has attracted extensive attention due to its non-toxic, non-polluting, non-combustible, low price, chemical inertness, recyclability and supercritical fluid properties. However, there is no prior art that can convert SC-CO 2 Report on the application of technology in the preparation process of CD-MOF. Summary of the invention

[0003] 1. Technical issues to be resolved

[0004] In view of the above-mentioned shortcomings and deficiencies of the prior art, the present invention provides a method and application of using supercritical carbon dioxide to assist in preparing cyclodextrin metal organic framework materials. 2 Filled with methanol vapor and K+ and γ-cyclodextrin in a closed reactor, + Highly stable nanoscale CD-MOF materials are prepared through coordination with γ-cyclodextrin. This method can reduce the amount of methanol used, greatly shorten the process time, reduce the leakage risk caused by long-term methanol vapor diffusion, and improve the yield and preparation efficiency of CD-MOF.

[0005] (II) Technical solution

[0006] In a first aspect, the present invention provides a method for preparing a cyclodextrin metal organic framework material using supercritical carbon dioxide, which comprises:

[0007] S1, dissolving γ-cyclodextrin and a water-soluble potassium salt in water to obtain a mixed solution, filtering the mixed solution through a filter membrane into a container, adding methanol so that the volume ratio of methanol to water is 3-7:1-5, and obtaining a reaction solution;

[0008] S2, transferring the reaction solution to a high-pressure reactor and preheating the temperature;

[0009] S3, charging CO into the high pressure reactor 2 Heat and stir until the pressure reaches 8-14 MPa, and the reaction time is 15-120 min;

[0010] S4. After the reaction is completed, the autoclave is naturally cooled to room temperature and then the pressure is released. The reactants in the autoclave are transferred out, PEG20000 methanol solution is added to mix with the reactants, and the mixture is placed in cold water and allowed to stand for 2-4 hours.

[0011] S5. Centrifuge at 5000-10000 rpm, collect the precipitate, wash, and dry to obtain a cyclodextrin metal organic framework material CD-MOF.

[0012] According to a preferred embodiment of the present invention, in S1, the water-soluble potassium salt is potassium hydroxide; in the mixed solution, the molar ratio of γ-cyclodextrin to potassium ions is 1:6-10, preferably 1:8; and the potassium ion concentration in the mixed solution is 0.2-1 mol / L.

[0013] According to a preferred embodiment of the present invention, in S1, the mixed solution is filtered into a container using a filter membrane with a pore size of 0.45 μm, methanol is added, and ultrasonic treatment is performed for 3-8 minutes to completely dissolve the γ-cyclodextrin in the filtrate and to uniformly mix the methanol and the filtrate.

[0014] According to a preferred embodiment of the present invention, in S2, an oil bath is used for preheating at 40-70°C. In S2, the reaction liquid is preferably transferred to a high-pressure reactor with a volume 2-4 times the volume of the reaction liquid. If the volume of the high-pressure reactor is too large, more high-pressure CO needs to be charged. 2The reaction results in high pressure CO 2 The gas source consumption is large, so a high-pressure reactor of appropriate volume should be selected.

[0015] According to a preferred embodiment of the present invention, in S4, the concentration of PEG20000 methanol solution is 5-15 mg / mL, preferably 8 mg / mL. Preferably, the temperature of cold water is 4-25°C, preferably 10-25°C. Preferably, the volume of PEG20000 methanol solution is 0.5-2 times the volume of the reactants, the added volume is related to the concentration of PEG20000 methanol solution, the amount of PEG20000 added is 0.3-0.5 times the mass of γ-CD, and preferably the volume of PEG20000 methanol solution is equal to the volume of the reactants transferred out of the autoclave.

[0016] PEG20000 plays a crucial role in the size of CD-MOF crystals. When PEG20000 is added to the crystallization medium, the PEG20000 molecules cover the surface of the CD-MOF crystals, thereby slowing down the growth rate of the crystals and reducing the final crystal size.

[0017] According to a preferred embodiment of the present invention, in S5, the washing is performed by washing with isopropanol and ethanol for several times respectively; and the drying is performed by forced air drying at 60° C. for 5 hours to obtain the product.

[0018] According to a preferred embodiment of the present invention, in S5, the reactants in the autoclave are transferred out and centrifuged at 8000 rpm for 5 minutes to collect the precipitate.

[0019] In a second aspect, the present invention provides a method for preparing a drug-loaded cyclodextrin metal-organic framework material, which includes a preparation process of the cyclodextrin metal-organic framework material. The preparation process of the cyclodextrin metal-organic framework material is as described in any of the above embodiments.

[0020] Preferably, the preparation method comprises: dissolving and mixing the drug and CD-MOF in a methanol solution, stirring the reaction under heating conditions in a water bath, collecting the product by centrifugation, washing, and drying to obtain a drug-loaded cyclodextrin metal organic framework material.

[0021] Preferably, the drug is a natural drug small molecule, such as quercetin, silymarin, curcumin, luteolin, paclitaxel, etc.

[0022] Preferably, the mass ratio of the drug to CD-MOF is 3-5:10, the water bath heating temperature is 40-60°C, the stirring speed is 600-1000rpm, the reaction is 15-120min, and the product is collected by centrifugation at 8000rmp for 5min. The product is washed with methanol 3 times, placed in an oven, and dried at 50°C for 4h to obtain a drug-loaded cyclodextrin metal organic framework material.

[0023] (III) Beneficial effects

[0024] The method of the present invention innovatively uses SC-CO 2 It is mixed with the organic solvent methanol as an organic solvent, and based on the basic principle of the vapor diffusion method, a highly stable nano-scale CD-MOF material is synthesized through coordination under mild operating conditions. The present invention effectively improves the problems of the traditional method, such as long time consumption, large amount of organic solvent consumption, low yield, high time and energy consumption, and easy leakage of toxic organic solvents.

[0025] The present invention uses potassium ion (K + ) as metal salt ions, γ-cyclodextrin (γ-CD) as organic ligand, and CO 2 It has both gas diffusion properties and liquid solubility, using supercritical CO 2 This property of methanol vapor assisted the diffusion of potassium ions and γ-CD to synthesize nanoscale CD-MOF materials through coordination. The CD-MOF materials have the advantages of high stability and good drug loading performance. 2 It has excellent organic solubility, can replace part of methanol, reduce the amount of methanol used, and improve the preparation rate. The invention has the advantages of mild preparation conditions, simple process, low energy consumption, green and environmental protection, etc. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 SEM images of CD-MOF prepared at different reaction temperatures in Example 1.

[0027] Figure 2 SEM images of CD-MOF prepared at different reaction pressures in Example 2.

[0028] Figure 3 SEM images of CD-MOF prepared at different reaction times in Example 3.

[0029] Figure 4 SEM images of CD-MOF prepared with different water / methanol ratios in Example 4.

[0030] Figure 5 This is the XRD pattern of CD-MOF prepared in Example 5.

[0031] Figure 6 These are the XRD results of the stability of the CD-MOF prepared in Example 5 in solvents such as N,N-dimethylformamide, ethanol, dichloromethane and isopropanol.

[0032] Figure 7 XRD patterns of CD-MOF and QUE@CD-MOF before drug loading.

[0033] Figure 8 SEM images of CD-MOF and QUE@CD-MOF before drug loading.

[0034] Fig. 9 BET test results of CD-MOF and QUE@CD-MOF before drug loading.

[0035] Fig.10 The dissolution rate change curves of QUE and QUE@CD-MOF in pH = 1.2, 6.8 and 7.4 solutions. DETAILED DESCRIPTION

[0036] In order to better explain the present invention and facilitate understanding, the present invention is described in detail below through specific implementation modes in conjunction with the accompanying drawings.

[0037] Example 1

[0038] This embodiment provides a method for preparing a cyclodextrin metal organic framework material using supercritical carbon dioxide, and the steps are as follows:

[0039] (1) Weigh 0.648 g of γ-cyclodextrin (0.5 mmol) and 0.224 g of potassium hydroxide (0.004 mol), dissolve in 4 mL of water, filter using a 0.45 μm filter, add 28 mL of methanol, and sonicate for 5 min until the solid reagent in the solution is completely dissolved; the molar ratio n(γ-CD):n(KOH)=1:8.

[0040] (2) The mixed solution was transferred to a 50 mL high pressure reactor, placed in an oil bath, and the reaction temperature was controlled at 40°C, 50°C, 60°C, and 70°C for sufficient preheating;

[0041] (3) After preheating, charge CO 2 When the pressure reaches 12 MPa, heat and stir to react for 2 h;

[0042] (4) After the reactor was naturally cooled to room temperature, the pressure was released, 30 mL of 8 mg / mL PEG20000 methanol solution was added to the reaction system and mixed, and the mixture was allowed to stand in cold water for 3 h;

[0043] (4) Centrifuge at 8000 rpm for 5 min to collect the precipitate;

[0044] (5) The obtained product particles were washed several times with isopropanol and ethanol respectively, and dried under forced air at 60°C for 5 h. The obtained product was CD-MOF.

[0045] like Figure 1 As shown, Figure 1A is the SEM image of the product CD-MOF prepared at 12MPa and 40℃ for 2h at 10k times. Figure 1 B is the SEM image of the product CD-MOF prepared at 12MPa and 50℃ for 2h at 10k times. Figure 1 C is a SEM image of the product CD-MOF prepared at 12MPa and 60℃ for 2h at 10k times. Figure 1 D is a SEM image of the product CD-MOF prepared at 12MPa and 70℃ for 2h at 10k times. As shown in the figure, the higher the reaction temperature, the more uniform the particle size distribution of the obtained product, the closer the shape of the nanosheet product is to the regular cubic structure, and the higher the dispersion of the product; among them, the product CD-MOF prepared under the conditions of 12MPa and 70℃ for 2h has the best microscopic morphology.

[0046] Example 2

[0047] In this embodiment, the "CO" in step (3) 2 Until the pressure is maintained at 12MPa" is changed to "CO 2 The reaction was continued for 2 h under pressure conditions such as 8, 10, 12, and 14 MPa. For other conditions and preparation steps, see Example 1.

[0048] like Figure 2 As shown, Figure 2 E is the SEM image of the product CD-MOF prepared at 8MPa and 70℃ for 2h at 10k times. Figure 2 F is the SEM image of the product CD-MOF prepared at 10 MPa and 70 ° C for 2 h at 10k times. Figure 2 G is the SEM image of the product CD-MOF prepared at 12MPa and 70℃ for 2h at 10k times. Figure 2 H is a SEM image of the product CD-MOF prepared at 14 MPa and 70°C for 2 hours at 10k times. As shown in the figure, the greater the reaction pressure, the more uniform the particle size distribution of the obtained product, the closer the shape of the nanosheet product is to the regular cubic structure, and the higher the dispersion of the product; among them, the product CD-MOF prepared under the conditions of 14 MPa and 70°C for 2 hours has the best microscopic morphology.

[0049] Example 3

[0050] In this example, the "heating and stirring reaction for 2 h" in step (3) is changed to "heating and stirring reaction for 15 min, 30 min, 1 h and 2 h". Other conditions and preparation steps are as in Example 1.

[0051] like Figure 3 As shown, Figure 3I is the amount of CO charged 2 The SEM image of the product CD-MOF prepared by maintaining the pressure at 14 MPa for 15 min is 10k times larger. Figure 3 G is charged with CO 2 The SEM image of the product CD-MOF prepared by maintaining the pressure at 14 MPa for 30 min is 10k times larger. Figure 3 K is charged into CO 2 The SEM image of the product CD-MOF prepared by maintaining the pressure at 14 MPa for 1 h is 10k times larger. Figure 3 L is charged with CO 2 The SEM image of the product CD-MOF prepared by maintaining the pressure at 14 MPa for 2 h is 10K times larger. By comparison, it can be found that the longer the reaction time, the more uniform the particle size distribution of the obtained product, the closer the shape of the nanosheet product is to the regular cubic structure, and the higher the dispersion of the product; 2 The product CD-MOF prepared by maintaining the pressure at 14MPa and 70℃ for 2h has the best microstructure.

[0052] Example 4

[0053] In this example, the "4 mL water, 28 mL methanol" in step (1) was changed to "10.6 mL water, 21.2 mL methanol; water: methanol = 1:2", "8 mL water, 24 mL methanol; water: methanol = 1:3", "6.4 mL water, 25.6 mL methanol; water: methanol = 1:4" and "4 mL water, 28 mL methanol; water: methanol = 1:7" and other conditions. For other conditions and preparation steps, see Example 1.

[0054] like Figure 4 As shown, Figure 4 M is the SEM image of the product CD-MOF prepared at 300 times the magnification under "10.6 mL water, 21.4 mL methanol", 14 MPa, and 70 ° C for 2 h. Figure 4 N is the SEM image of the product CD-MOF prepared in "8 mL water, 24 mL methanol" at 300 times, Figure 4 O is a SEM image of the product CD-MOF prepared in "6.4 mL water, 25.6 mL methanol" at 5k times, Figure 4 The SEM image of the product CD-MOF prepared under the condition of "4mL water, 28mL methanol" at 10k times of P. As shown in the figure, the larger the methanol: water ratio, the smaller the particle size of the obtained product and the higher the dispersion of the product; among them, the particle size of the product CD-MOF prepared under the condition of "4mL water, 28mL methanol" is the smallest and the dispersion of the product is the highest.

[0055] Example 5

[0056] This embodiment provides a method for preparing a cyclodextrin metal organic framework material using supercritical carbon dioxide, and the steps are as follows:

[0057] (1) Weigh 0.648 g of γ-cyclodextrin and 0.224 g of potassium hydroxide, dissolve in 4 mL of water, filter using a 0.45 μm filter, add 28 mL of methanol, and sonicate for 5 min until the solid reagent in the solution is completely dissolved;

[0058] (2) The mixed solution was transferred to a 50 mL autoclave and preheated in an oil bath at 70 °C;

[0059] (3) After preheating, charge CO 2 When the pressure reaches 14 MPa, heat and stir to react for 2 h;

[0060] (4) After the reactor was naturally cooled to room temperature, the pressure was released, 30 mL of 8 mg / mL PEG20000 methanol solution was added to the reaction system and mixed, and the mixture was allowed to stand in cold water for 3 h;

[0061] (4) Centrifuge at 8000 rpm for 5 min to collect the precipitate;

[0062] (5) The obtained product particles were washed several times with isopropanol and ethanol respectively, and dried under forced air at 60°C for 5 h. The obtained product was CD-MOF.

[0063] It can be seen from the above examples that the product particles are cubic in shape, and as the temperature rises, the pressure increases, the time becomes longer, and the water-to-alcohol ratio becomes smaller, the particle size becomes smaller and smaller, and the dispersion becomes higher and higher. The optimal preparation conditions are 14 MPa and 70°C for 2 hours.

[0064] The product prepared in this example was characterized by XRD. Figure 5 As shown in the figure, CD-MOF has clear diffraction peaks at 4°, 5.7°, 6.9°, 13.4° and 16.7°, which is consistent with the calculation simulation results, indicating that CD-MOF has a complete crystal structure and good crystal form.

[0065] The CD-MOF prepared in Example 5 was dispersed in N,N-dimethylformamide, ethanol, dichloromethane and isopropanol, immersed for 12 h at room temperature and pressure, centrifuged, and dried with air at 60°C. XRD detection was performed to confirm the stability of CD-MOF in different solvents. The test results are shown in FIG. Figure 6As shown in the figure. After solvent treatment, CD-MOF has good stability in isopropanol and ethanol, but slightly poor stability in N,N-dimethylformamide and dichloromethane. But overall, CD-MOF has corresponding characteristic diffraction peaks in XRD before and after different solvent treatments, which shows that it has good stability in all four solvents.

[0066] Example 6

[0067] In this example, the CD-MOF prepared in Example 5 was used as a drug carrier for drug loading.

[0068] Quercetin (QUE) is a representative compound of flavonols with high medicinal value and biological activity, but its poor water solubility seriously limits its application in drug therapy. In order to improve the dispersion and utilization rate of drugs, this example uses the impregnation method to prepare quercetin-loaded cyclodextrin metal organic framework drug-loaded microparticles, recorded as QUE@CD-MOF. The experimental method is as follows:

[0069] (1) 40 mg of quercetin and 100 mg of CD-MOF (prepared in Example 5) were accurately measured and dissolved in 20 mL of methanol solution, ultrasonically treated for 10 min to fully dissolve them, and then transferred to a round-bottom flask and reacted in a water bath with a set temperature of 50° C. and a rotation speed of 800 rpm. The reaction was completed when the set time was 1 h.

[0070] (2) After the reaction is completed, the reaction product in the round-bottom flask is taken out and transferred to a centrifuge tube. The product is centrifuged at a speed of 8000 rpm for 5 minutes. After the centrifugation is completed, the supernatant is taken out from the centrifuge tube and washed with methanol solution three times.

[0071] (3) After washing, the precipitate obtained by centrifugation was placed in an oven and dried at 50 °C for 4 h to obtain QUE@CD-MOF drug-loaded microparticles.

[0072] XRD tests were performed on QUE@CD-MOF and CD-MOF before drug loading. The test results are as follows: Figure 7As shown in the figure, CD-MOF shows clear diffraction peaks at 4°, 5.7°, 6.9°, 13.4° and 16.7°. QUE has characteristic diffraction peaks at 5.36°, 10.76°, 12.46°, 16.13°, 23.88°, 27.42°, etc., and the strongest characteristic diffraction peak appears at 12.46°. This shows that QUE has a good crystal form. QUE@CD-MOF has characteristic peaks of CD-MOF at 4°, 5.7°, 6.9°, 13.4° and 16.7°. Compared with CD-MOF alone, the characteristic peak intensity of QUE@CD-MOF changes slightly, but there is no obvious difference overall, which proves that QUE enters the CD-MOF cavity in an amorphous state, and explains that the process of drug loading will not affect the crystal structure of CD-MOF, providing a basis for it to be used as a drug carrier.

[0073] like Figure 8 The figure shows the SEM images of CD-MOF before and after drug loading, where A and B are the SEM images before drug loading, and C and D are the SEM images of QUE@CD-MOF after drug loading. As can be seen from the figure, there is no obvious difference in the morphology of CD-MOF particles after QUE loading and CD-MOF alone, both of which are uniform cubic structures, indicating that the overall structure of the CD-MOF material will not be affected during the drug loading process.

[0074] The QUE@CD-MOF of this example was subjected to BET testing and compared with the CD-MOF before drug loading. The test results are as follows: Fig. 9 As shown in Figure 2, the nitrogen adsorption / desorption isotherms of drug-loaded QUE@CD-MOF and CD-MOF before drug loading are shown in A, and the pore size distribution of drug-loaded QUE@CD-MOF and CD-MOF before drug loading is shown in B. After drug loading, the specific surface area (m 2 / g), pore size (nm) and pore volume (cc / g) are significantly reduced, which indicates that QUE has been loaded into the pore structure of CD-MOF. The specific comparison results are as follows:

[0075] <![CDATA[Specific surface area (m 2 / g)]]> Pore ​​size (nm) Pore ​​volume (cc / g) Before drug loading 894.120 1.442 0.138 After drug loading 575.741 1.411 0.119

[0076] Example 7

[0077] This example further conducts a drug dissolution experiment on the QUE@CD-MOF drug-loaded microparticles prepared in Example 6, and the implementation method is as follows:

[0078] (1) Prepare the following solution:

[0079] (A) Take 117 mL of concentrated hydrochloric acid and dilute it in a 500 mL measuring cylinder, then transfer 24 mL to a 1000 mL measuring cylinder and dilute with degassed water, pH = 1.2. Solution (A) can simulate the gastric fluid environment.

[0080] (B) Weigh 6.9 g of sodium dihydrogen phosphate and 0.9 g of sodium hydroxide solid, dissolve in 1000 mL of water, pH = 6.8. Solution (B) can simulate the small intestine environment.

[0081] (C) Weigh 1.36 g of potassium dihydrogen phosphate, add 79 mL of 0.1 mol / L sodium hydroxide solution, dilute with water to 200 mL, pH = 7.4. Solution (C) can simulate the blood environment.

[0082] (2) The dissolution rates of QUE and QUE@CD-MOF were measured by the slurry method using three buffer solutions (A), (B), and (C).

[0083] Weigh QUE and QUE@CD-MOF samples based on 2.5 mg QUE, take 500 mL of each of the three buffer solutions (A), (B) and (C), add the sample to the buffer solution, set the equipment temperature to 37°C and the speed to 100 rpm, take liquid at different time intervals to measure the QUE concentration in the solution, take liquid 11 times in total (2, 5, 8, 13, 20, 30, 40, 55, 75, 100, 130 min), take 10 mL of liquid each time, replenish 10 mL of liquid, and filter the taken sample through a 0.45 μm microporous filter membrane into the sampling tube. After the liquid is taken, use a UV spectrophotometer to measure the absorbance of the sample at 372 nm. Substitute into the standard curve and calculate the solubility. The test results are as follows: Fig.10 shown.

[0084] As can be seen from the figure, at each moment under the same pH conditions, the dissolution rate of the drug QUE in the QUE@CD-MOF drug-loaded particles is much greater than the QUE dissolution rate; after 40 minutes of dissolution experiment, under the three conditions of pH = 1.2, 6.8 and 7.4, the dissolution rate of QUE stabilized at 20% and could not continue to rise, while the drug dissolution rate of QUE@CD-MOF reached more than 70% after 40 minutes, especially under the environment of pH = 7.4, the drug dissolution rate of QUE@CD-MOF reached 96.28%.

[0085] In summary, after loading QUE on CD-MOF, the present invention can greatly improve the effective dissolution rate of QUE and effectively promote the bioavailability of QUE.

[0086] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.

Claims

1. A method for preparing cyclodextrin metal organic framework materials using supercritical carbon dioxide, characterized in that: It includes: S1. Dissolving γ-cyclodextrin and a water-soluble potassium salt in water to obtain a mixed solution, filtering the mixed solution through a filter membrane into a container, adding methanol so that the volume ratio of methanol to water is 3-7:1-5, and obtaining a reaction solution; S2, transferring the reaction solution to a high-pressure reactor and preheating the temperature; S3, charging CO2 into the autoclave until the pressure reaches 8-14 MPa, heating and stirring for reaction, the reaction time is 15-120 min; S4. After the reaction is completed, the autoclave is naturally cooled to room temperature and then the pressure is released. The reactants in the autoclave are transferred out, PEG20000 methanol solution is added to mix with the reactants, and the mixture is placed in cold water and allowed to stand for 2-4 hours. S5. Centrifuge at 5000-10000 rpm, collect the precipitate, wash, and dry to obtain a cyclodextrin metal organic framework material CD-MOF.

2. The method according to claim 1, characterized in that In S1, the water-soluble potassium salt is potassium hydroxide; in the mixed solution, the molar ratio of γ-cyclodextrin to potassium ions is 1:6-10; and the concentration of potassium ions in the mixed solution is 0.2-1 mol / L.

3. The method according to claim 1, characterized in that In S1, the mixed solution is filtered into a container using a filter membrane with a pore size of 0.45 μm, methanol is added, and ultrasonication is performed for 3-8 minutes to completely dissolve the γ-cyclodextrin and potassium hydroxide in the filtrate and to uniformly mix the methanol and the filtrate.

4. The method according to claim 1, characterized in that: In S2, an oil bath was used to preheat the reaction at 40-70°C.

5. The method according to claim 1, characterized in that In S4, the concentration of the PEG20000 methanol solution is 5-15 mg / mL; the PEG20000 methanol solution and the reactants are mixed in equal volumes.

6. The method according to claim 1, characterized in that In S5, the washing step is performed by washing with isopropanol and ethanol for several times respectively; and the drying step is performed by forced air drying at 60° C. for 5 h to obtain the product.

7. A method for preparing a drug-loaded cyclodextrin metal organic framework material, characterized in that: The invention comprises a preparation process of a cyclodextrin metal organic framework material, and the preparation method of the cyclodextrin metal organic framework material is the method described in any one of claims 1 to 6.

8. The method for preparing the drug-loaded cyclodextrin metal organic framework material according to claim 7, characterized in that: include: The drug and CD-MOF are dissolved and mixed in a methanol solution, stirred for reaction under a water bath heating condition, the product is collected by centrifugation, washed, and dried to obtain a drug-loaded cyclodextrin metal-organic framework composite material.

9. The method for preparing the drug-loaded cyclodextrin metal organic framework material according to claim 7, characterized in that: The drug is quercetin.

10. The method for preparing the drug-loaded cyclodextrin metal organic framework material according to claim 7, characterized in that: The mass ratio of the drug to CD-MOF is 3-5:10, the water bath heating temperature is 40-60° C., the stirring speed is 600-1000 rpm, the reaction time is 15-120 min, and the product is collected by centrifugation at 8000 rpm for 5 min.

Citation Information

Patent Citations

  • Rapid synthesis method of cyclodextrin-metal organic framework material

    CN107151329A

  • Preparation method of cyclodextrin metal organic framework stably existing in water phase

    CN114656645A

Cited By

  • ZIF-8 metal framework material as well as preparation method and application thereof

    CN122404741A